Elizabeth Budde, M.D., Ph.D. is a well-recognized translational and clinical physician researcher in the area of blood cancers. She leads the Immunotherapy Modality Team and is the executive medical director, Enterprise Immune Effector Cell Program at City of Hope National Medical Center. Dr. Budde has received many honors and awards for her work. She has published more than 100 peer-reviewed articles in prominent journals including the Lancet Oncology, Nature Medicine, Journal of Clinical Oncology, Blood, and Clinical Cancer Research. Dr. Budde holds patents for new drugs currently under development in lymphoma and leukemia and is the principal investigator of innovative translational research protocols and maintains a dynamic portfolio of clinical trials and a research laboratory.